NCT04284657View on ClinicalTrials.gov

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

August 4, 2025

Study Completion Date

August 4, 2025

Conditions
Autosomal Dominant Polycystic Kidney Disease
Interventions
DRUG

Pravastatin

Pravastatin 40 mg QD

DRUG

sodium citrate

sodium citrate up to 30 ml TID

Trial Locations (1)

90033

Keck School of Medicine of University of Southern California, Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT04284657 - Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease | Biotech Hunter | Biotech Hunter